CellaVision AB: Good profitability despite negative COVID-19-effect
CellaVision AB presents the second quarter for 2020
CellaVision AB: Bulletin from AGM held on June 16, 2020
CellaVision AB: Zlatko Rihter leaves his position as CEO at CellaVision AB
CellaVision AB: CellaVisions Annual report for 2019 is now available
CellaVision AB: Notice of the Annual General Meeting 2020
CellaVision AB: Stable start of the year with good growth in APAC
CellaVision AB presents the first quarter for 2020 on April 22, at 11:00 CET
CellaVision AB: The Annual General Meeting of CellaVision AB (publ) is postponed and the Board of Directors has decided to withdraw the proposed dividend due to the coronavirus, Covid-19
CellaVision AB: Notice of 2020 Annual General Meeting of CellaVision (publ)
CellaVision AB: Nomination Committee proposes re-election of Chairman and members to the Board of Directors
CellaVision AB: Year-end bulletin, Jan-Dec 2019
CellaVision AB presents the year-end bulletin for 2019 on February 5 at 11:00 CET
CellaVision AB: Continued growth and acquisition of RAL Diagnostics
CellaVision AB presents the third quarter for 2019 on October 23 at 11:00 CET
CellaVision completes the acquisition of RAL Diagnostics
CellaVision invites to a telephone and audio webcast on September 17, at 11:00 CET to present the signing of an agreement to acquire the French company RAL Diagnostics
CellaVision AB to acquire RAL Diagnostics
CellaVision ABs strongest quarter ever with continued growth
CellaVision AB presents the second quarter for 2019 on July 16 at 11:00 CET
CellaVision AB: Bulletin from AGM held on May 8, 2019
CellaVision AB: Interim report January-March 2019
CellaVision AB presents the first quarter for 2019 on May 7 at 11:00 CET
CellaVision AB: CellaVisions Annual report for 2018 is now available
CellaVision AB: Notice of 2019 Annual General Meeting of CellaVision (publ)
CellaVision AB: Nomination Committee proposes re-election of Chairman and members to the Board of Directors.
CellaVision AB Year-end bulletin, Jan-Dec 2018
CellaVision AB launches new product, CellaVision® DC-1, for small and mid-sized hematology laboratories
CellaVision AB presents the year-end bulletin for 2018 on February 7 at 11:00 CET
CellaVision AB: Interim report January-September 2018
Older releases »

Subscribe to updates

It's possible to subscribe to CellaVision's press releases, financial information by e-mail and SMS.

Click here to register


Information request

Are you looking for some particular information about our company or our business?

Click here to get in touch


Analyst

ABG Sundal Collier AB
Victor Forssell
victor.forssell@abgsc.se
+46 8 566 286 92

Rickard Anderkrans
rickard.anderkrans@abgsc.se
+46 8 566 286 73

Carnegie
Ulrik Trattner
ulrik.trattner@carnegie
+46 8 5886 8589

Kristofer Liljeberg
kristofer.liljeberg@carnegie.se
+46 8 5886 87 63

Pareto Securities AB
Christian Lee
christian.lee@paretosec.com
+46 84 02 52 67

Johan Unnérus
johan.unnerus@paretosec.com
+46 8 402 52 68

 

Access our Student Resources

To access this resource, please provide the following information about yourself.